Media hub

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney has shown strong potential to protect against both current and emerging coronavirus variants. By targeting features shared by a range of coronaviruses, the vaccine is designed to offer broader and longer-lasting protection as the virus continues to evolve.

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and haemophilia.

Researchers from the Centenary Institute have uncovered a reason why some people with haemophilia A develop resistance to their critical treatment, paving the way for the development of more effective therapies.

Researchers from the Centenary Institute, in collaboration with the University of Sydney, have developed a powerful new tool to evolve proteins directly within mammalian cells, offering a more effective way to design medical treatments tailored to the human body.

New research from the Centenary Institute has found that switching off a specific protein in liver cells may help prevent the early development of liver cancer.

Each week in Australia, up to three young people die suddenly and unexpectedly from sudden cardiac death, often due to an undiagnosed genetic heart condition. These conditions typically go unnoticed until tragedy strikes, leaving families devastated and searching for answers.

A team led by Dr Chuck Bailey at the Centenary Institute has been awarded a National Health and Medical Research Council (NHMRC) Ideas Grant to develop safer and more effective gene therapies.

The Centenary Institute has received important funding from the RT Hall Trust to bolster two ground-breaking cancer research initiatives. Almost one in two Australians will be diagnosed with cancer by the age of 85. Cancer is a leading cause of death, claiming around 50,000 Australians annually.

New research from the Centenary Institute and the University of Sydney has uncovered important insights into the immune environment within liver cancer, the sixth most common cancer worldwide and the third leading cause of cancer-related deaths.

Centenary Institute researcher Dr Alex Cole has been awarded a $100,000 Ramaciotti Health Investment Grant to support his research into improving the safety and precision of gene therapy treatments.

Dr Mark Schreuder, a researcher at the Centenary Institute’s Centre for Cancer Innovations, has received the Kenyon Foundation Inflammation Award for 2024.

New research from the Centenary Institute has identified specific blood fats that can predict how effectively individuals with pre-diabetes will improve their blood sugar levels through diet and weight loss. These findings could pave the way for more personalised approaches to preventing and managing type 2 diabetes.